Publications
Teratology Primer, 3rd Edition
Which Infections Increase the Risk of Birth Defects?
Sonja A. Rasmussen, Centers for Disease Control and Prevention, Atlanta, Georgia
Amelia K. Watson, University of Florida College of Medicine, Gainesville, Florida
Margaret A. Honein, Centers for Disease Control and Prevention, Atlanta, Georgia
The findings and conclusions in this chapter are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
The identification of Zika virus as a cause of birth defects has renewed interest in infectious causes of birth defects. Certain infections during pregnancy have long been known to cause birth defects. The effects of rubella during pregnancy were first described in 1941 by Dr. Norman Gregg, an Australian ophthalmologist who identified a particular type of cataract in infants born to women infected with rubella virus (German measles) during pregnancy. The findings in infants whose mothers had been infected with rubella virus during pregnancy were later expanded beyond cataracts to include hearing loss, heart defects, and intellectual disability (termed congenital rubella syndrome). Since then, infections with other pathogens during pregnancy have been identified as causes of adverse pregnancy and birth outcomes, including structural birth defects (Table).
Other infections (e.g., influenza) have not been specifically recognized as a cause of birth defects, but fever, which often occurs with infection, has been associated with an increased risk for certain birth defects, including a doubling in the risk for neural tube defects, including spina bifida and anencephaly. Some infections are suspected to increase the risk for adverse pregnancy outcomes (e.g., Japanese encephalitis virus has been suspected to increase the risk for pregnancy loss, based on evidence from case series), but the increased risk has not been well documented. Some infections pass from mother to infant during pregnancy but have not been found to increase the risk of birth defects (e.g., human immunodeficiency virus [HIV]), although HIV-induced immunosuppression increases the risk of other infections that can increase the risk of birth defects. For most infections, the risk of adverse pregnancy and birth outcomes is unknown because systematic studies have not been performed.
Several different types of adverse pregnancy and birth outcomes, ranging from pregnancy loss to structural birth defects apparent at birth, to developmental disabilities observed after birth, have been associated with infections during pregnancy. Infectious causes of adverse pregnancy and birth outcomes include viruses (cytomegalovirus [CMV], herpes simplex-2 (HSV-2), lymphocytic choriomeningitis virus [LCMV], parvovirus B19, rubella, varicella, Venezuelan equine encephalitis virus, Zika virus), bacteria (Treponema pallidum, Listeria monocytogenes), and parasites (Toxoplasma gondii). Some infectious pathogens increase the risk for pregnancy loss (e.g., Listeria monocytogenes and parvovirus B19), while others increase the risk for birth defects that are evident at birth (e.g., rubella and Zika viruses). Several infectious pathogens increase the risk for defects of the brain and eye, including CMV, LCMV, Toxoplasma gondii, and Zika virus. Some infections during pregnancy (e.g., CMV) can cause problems, such as hearing loss, which appear several months after birth in infants with no apparent problems at birth.
As with other teratogenic exposures during pregnancy, the timing of an infection during pregnancy affects the types and frequencies of adverse outcomes observed. For example, the risk of birth defects from first trimester rubella infection may be as high as 100 percent, and includes eye abnormalities, congenital heart defects, defects of the central nervous system, hearing loss and intrauterine growth retardation. Infection in the second trimester poses a lower risk of abnormalities, and the types of abnormalities include hearing loss, retinopathy, microcephaly, and cognitive impairment. Third trimester rubella infection is associated with a much lower risk to the fetus, primarily of intrauterine growth retardation, rather than of birth defects or developmental disabilities.
Infections that cause adverse pregnancy and birth outcomes have different primary routes of transmission, including exposure to infected saliva and urine of infected persons (CMV), fresh urine, droppings, saliva, or nesting materials from infected rodents (LCMV), contaminated foods (Listeria monocytogenes ), undercooked foods and cat feces (Toxoplasma gondii), bites of infected mosquitoes (Zika virus), and sexual contact (syphilis and Zika virus). Depending on the type of infection, approaches to prevention differ (Table). For most infections, avoidance of exposure (e.g., avoidance of mosquito bites, rodents, contaminated foods, or contact with infected persons) is the primary prevention strategy. For women who have contracted syphilis during pregnancy, early recognition and treatment can be effective in preventing congenital syphilis. The most successful program for prevention of birth defects that occur after infection during pregnancy is the rubella vaccination program. Following development of a vaccine against rubella and a comprehensive vaccination program, rubella and congenital rubella syndrome have been eliminated from the United States, and progress toward elimination is being made in other countries throughout the world.
Table: Infections that Cause Adverse Pregnancy and Birth Outcomes Following Exposures during Pregnancy |
||||||
Infection |
Pathogen |
Most Common Routes of Exposure |
Potential Strategies for Pregnant Women to Reduce Risk |
Adverse Pregnancy and Birth Outcomes |
CDC Website (if available) |
|
Cytomegalovirus (CMV) |
Cytomegalovirus – Herpesviridae family |
Direct contact with body fluids (e.g., urine, saliva) |
Avoid contact with saliva and urine from young children |
|
||
Herpes simplex virus 2 (HSV-2) |
Herpes simplex virus 2 – Herpesviridae family |
Sexual contact |
Avoid sexual contact with infected persons or use latex condoms |
|
||
Listeriosis |
Listeria monocytogenes - bacterium |
Consuming Listeria-contaminated foods |
Avoid consuming foods potentially contaminated with Listeria (e.g., soft cheese made with raw milk, raw or lightly cooked sprouts, and hot dogs, lunch meats, cold cuts, other deli meats, or fermented or dry sausages unless they are heated to an internal temperature of 165°F or until steaming hot just before serving) |
|
||
Lymphocytic Choriomeningitis Virus (LCMV) |
Lymphocytic choriomeningitis virus - Arenaviridiae family |
Contact with urine, feces, saliva, or blood of infected rodents (common house mouse, hamsters and other pet rodents) |
Avoid contact with mice and pet rodents during pregnancy |
|
||
Parvovirus B19 (erythema infectiosum, Fifth disease) |
Parvovirus B19 - Parvoviridae family |
Exposure to respiratory secretions from persons infected with parvovirus B19 |
Avoid contact with persons infected with Parvovirus B19, if susceptible |
|
||
Rubella (German measles) |
Rubella virus - Togaviridae family |
Direct or droplet contact from nasopharyngeal secretions |
Vaccinate with rubella-containing vaccine before pregnancy |
|
||
Syphilis |
Treponema pallidum - bacterium |
Sexual contact |
Avoid sexual contact with infected persons or use latex condoms
|
|
||
Toxoplasmosis |
Toxoplasma gondii – protozoan |
Consumption of undercooked contaminated meat |
Avoid consumption of undercooked meats |
|
||
Varicella (chickenpox) |
Varicella-zoster virus – Herpesviridae family |
Close contact with a person with varicella or herpes zoster |
Vaccinate with varicella vaccine before pregnancy if woman is determined to be susceptible |
|
||
Venezuelan Equine Encephalitis |
Venezuelan Equine Encephalitis virus – Togaviridae family |
Bite of infected mosquito |
Avoid bites of infected mosquitoes |
|
-- |
|
Zika virus |
Zika virus – Flaviviridae family |
Bite of infected mosquito |
Avoid bites of infected mosquitoes |
|
Suggested References
American Academy of Pediatrics Red book Online. https://redbook.solutions.aap.org/Redbook.aspx
Awofisayo A, Amar C, Ruggles R et al. 2015. Pregnancy-associated listeriosis in England and Wales. Epidemiol Infect 143:249-256.
Bonthius DJ. 2009. Lymphocytic choriomeningitis virus: a prenatal and postnatal threat. Adv Pediatr 56:75-86.
Centers for Disease Control and Prevention website. www.cdc.gov.
Davis NL, King CC, Kourtis AP. 2017. Cytomegalovirus infection in pregnancy. Birth Defects Res 109:336-346.
De Santis M, Cavaliere AF, Straface G, Caruso A. 2006. Rubella infection in pregnancy. Reprod Toxicol 21:390-398.
De Santis M, De Luca C, Mappa I et al. 2012. Syphilis Infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol 2012:430585.
Grant GB, Reef SE, Dabbagh A, Gacic-Dobo M, Strebel PM. 2015. Global Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - 2000-2014. MMWR Morb Mortal Wkly Rep 64:1052-1055.
Hampton MM. 2015. Congenital Toxoplasmosis: A Review. Neonatal Netw 34:274-278.
Kravetz J. 2013. Congenital toxoplasmosis. BMJ Clin Evid 2013.
Moore CA, Staples JE, Dobyns WB et al. 2017. Characterizing the Pattern of Anomalies in Congenital Zika Syndrome for Pediatric Clinicians. JAMA Pediatr 171:288-295.
Ornoy A, Ergaz Z. 2017. Parvovirus B19 infection during pregnancy and risks to the fetus. Birth Defects Res 109:311-323.
Ornoy A, Tenenbaum A. 2006. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol 21:446-457.
Tsimis ME, Sheffield JS. 2017. Update on syphilis and pregnancy. Birth Defects Res 109:347-352.
Wadhwa Desai R, Smith MA. 2017. Pregnancy-related listeriosis. Birth Defects Res 109:324-335.
Wang A, Wohrley J, Rosebush J. 2017. Herpes Simplex Virus in the Neonate. Pediatr Ann 46:e42-e46.
Wenger F. 1977. Venezuelan equine encephalitis. Teratology 16:359-362.
Yazigi A, De Pecoulas AE, Vauloup-Fellous C et al. 2017. Fetal and neonatal abnormalities due to congenital rubella syndrome: a review of literature. J Matern Fetal Neonatal Med 30:274-278.